Last Updated: November 9, 2026

List of Excipients in API prasugrel

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing prasugrel

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Eli Lilly and Company EFFIENT prasugrel hydrochloride 0002-5121 CELLULOSE, MICROCRYSTALLINE
Eli Lilly and Company EFFIENT prasugrel hydrochloride 0002-5121 FERRIC OXIDE YELLOW
Eli Lilly and Company EFFIENT prasugrel hydrochloride 0002-5121 GLYCERYL DIBEHENATE
Eli Lilly and Company EFFIENT prasugrel hydrochloride 0002-5121 HYPROMELLOSE
Eli Lilly and Company EFFIENT prasugrel hydrochloride 0002-5121 HYPROMELLOSE 2910
Eli Lilly and Company EFFIENT prasugrel hydrochloride 0002-5121 LACTOSE MONOHYDRATE
Eli Lilly and Company EFFIENT prasugrel hydrochloride 0002-5121 LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Start Trial

Excipients in ANDA-approved (generic) drugs containing prasugrel

Company Ingredient NDC Excipient
Mylan Pharmaceuticals Inc prasugrel 0378-5185 CROSPOVIDONE
Mylan Pharmaceuticals Inc prasugrel 0378-5185 FD&C YELLOW NO. 6
Mylan Pharmaceuticals Inc prasugrel 0378-5185 FERRIC OXIDE YELLOW
Mylan Pharmaceuticals Inc prasugrel 0378-5185 GLYCERYL DIBEHENATE
Mylan Pharmaceuticals Inc prasugrel 0378-5185 HYPROMELLOSE
Mylan Pharmaceuticals Inc prasugrel 0378-5185 LACTOSE MONOHYDRATE
Mylan Pharmaceuticals Inc prasugrel 0378-5185 MANNITOL
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Start Trial

Detailed excipient profiles for prasugrel

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: DIETHYL PHTHALATE

Excipient focus: ETHYLCELLULOSE

Excipient focus: ETHYLCELLULOSES

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GLYCERYL BEHENATE/EICOSADIOATE

prasugrel drug variants not containing GLYCERYL BEHENATE/EICOSADIOATE

Company Ingredient NDC
Mylan Pharmaceuticals Inc prasugrel 0378-5185
Accord Healthcare Inc prasugrel 16729-272
Unichem Pharmaceuticals (USA) Inc prasugrel 29300-301
A-S Medication Solutions prasugrel 50090-5169
Golden State Medical Supply Inc prasugrel 51407-444
American Health Packaging prasugrel 60687-412
American Health Packaging prasugrel 60687-741
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: GLYCERYL DIBEHENATE

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

prasugrel drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Company Ingredient NDC
Mylan Pharmaceuticals Inc prasugrel 0378-5185
Liberty Pharmaceuticals Inc prasugrel 0440-0604
Accord Healthcare Inc prasugrel 16729-272
Unichem Pharmaceuticals (USA) Inc prasugrel 29300-301
A-S Medication Solutions prasugrel 50090-4118
A-S Medication Solutions prasugrel 50090-5169
Golden State Medical Supply Inc prasugrel 51407-444
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

prasugrel drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

Company Ingredient NDC
Liberty Pharmaceuticals Inc prasugrel 0440-0604
Accord Healthcare Inc prasugrel 16729-272
Unichem Pharmaceuticals (USA) Inc prasugrel 29300-301
A-S Medication Solutions prasugrel 50090-5169
American Health Packaging prasugrel 60687-412
American Health Packaging prasugrel 60687-741
American Health Packaging prasugrel 60687-883
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

prasugrel drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

Company Ingredient NDC
Mylan Pharmaceuticals Inc prasugrel 0378-5185
Panacea Biotec Limited prasugrel 43817-239
A-S Medication Solutions prasugrel 50090-4118
Golden State Medical Supply Inc prasugrel 51407-248
Golden State Medical Supply Inc prasugrel 51407-444
Apotex Corp prasugrel 60505-4642
Amneal Pharmaceuticals LLC prasugrel 65162-001
>Company >Ingredient >NDC

Subscribe to access the full database, or Start Trial

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: STARCH, CORN

Excipient focus: STEARIC ACID

Excipient focus: SUCROSE STEARATE

Excipient focus: SUCROSE, 6-STEARATE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2026 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
 NCE-1 Patent Challenge Dates 2026 - 2027
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links